Jessica Flores - Feb 29, 2024 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Signature
/s/ Michael Costa, as Attorney-in-Fact
Stock symbol
SBRA
Transactions as of
Feb 29, 2024
Transactions value $
-$32,051
Form type
4
Date filed
3/4/2024, 01:35 PM
Previous filing
Feb 2, 2024
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBRA Common Stock Award $0 +409 +0.74% $0.00 55.5K Feb 29, 2024 Direct F1
transaction SBRA Common Stock Award $0 +5.98K +10.76% $0.00 61.5K Mar 1, 2024 Direct F2
transaction SBRA Common Stock Tax liability -$32.1K -2.29K -3.72% $13.99 59.2K Mar 1, 2024 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
F2 Represents shares of the Issuer's Common Stock issued under the Issuer's 2009 Performance Incentive Plan subject to an annual bonus performance stock unit ("PSU") award granted on June 13, 2023, including 328 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on March 1, 2024 that the number of PSUs earned was 200.0% of the target. Upon this determination, the PSUs vested and were paid out immediately. Each PSU represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of an adjusted normalized funds from operations per share target for a performance period beginning January 1, 2023 and ending December 31, 2023.
F3 Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.
F4 Includes 19,337 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.